According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.64. In 2021 the company made an earnings per share (EPS) of -$55.43.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.64 | |
2021 | -$55.43 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Sanofi SNY | $3.18 | -156.39% | ๐ซ๐ท France |
Baxter BAX | $5.12 | -190.78% | ๐บ๐ธ USA |
Omeros Corporation OMER | $0.64 | -111.35% | ๐บ๐ธ USA |
Geron GERN | -$0.34 | -93.97% | ๐บ๐ธ USA |
Genetic Technologies GENE | N/A | N/A | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | -$2.00 | -64.54% | ๐ฎ๐ฑ Israel |
Bio-Techne TECH | $1.57 | -127.84% | ๐บ๐ธ USA |